Search filters

List of works by Thomas M. File

"Management of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies"

scientific article published on 16 June 2020

1338. A Pooled Analysis of Patients With Wound Infections in the Phase 3 REVIVE Trials: Randomized, Double-blind Studies to EValuate the Safety and Efficacy of Iclaprim Vs. Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure Infection

1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsuscep

1374. Integrated Safety Summary of Omadacycline: A Novel Aminomethylcycline Antibiotic

1805. Impact of Antimicrobial Stewardship Interventions Using Rapid Molecular Testing on the Appropriate Use of Antiviral Therapy and Reduction of Unnecessary Antibiotic Therapy for Patients Admitted With Acute Influenza

1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections

2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Resul

2237. Early Discontinuation of Antibacterials Is Safe for Patients with Community-Acquired Pneumonia (CAP) Who Have a Positive Viral Test, Negative Tests for Bacteria, and Low Procalcitonin

2386. Efficacy of Lefamulin (LEF) vs. Moxifloxacin (MOX) Against Common Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Results From the Phase 3 Lefamulin Evaluation Against Pneumonia (LEAP 1) Study

663. Efficacy and Safety of Lefamulin (LEF) vs. Moxifloxacin (MOX) for Legionella pneumophila (LP) in Patients with Community-Acquired Bacterial Pneumonia (CABP): Pooled Results From the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Pha

664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positiv ⬇️

scientific article published on 21 December 2017

A Phase 3, Randomized, double-blind, multicenter study to EValuate the safety and efficacy of intravenous Iclaprim versus Vancomycin for the trEatment of acute bacterial skin and skin structure infections suspected or confirmed to be due to Gram-pos ⬇️

scientific article published on 12 March 2018

A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens ⬇️

scientific article

A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria

scientific article

A comparison of six antistaphylococcal antibiotics

scientific article published in March 1987

A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic

scientific article

A new dosing paradigm: high-dose, short-course fluoroquinolone therapy for community-acquired pneumonia

scientific article published on January 2003

A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections

scientific article published on 20 March 2020

A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation ⬇️

scientific article published on January 9, 2012

A worldwide perspective of atypical pathogens in community-acquired pneumonia.

scientific article published in March 2007

Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies

scientific article

Ambulatory management of lower respiratory tract infections

scientific article

Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections) ⬇️

scientific article published on August 29, 1983

An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic

scientific article published on 01 August 2019

An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy ⬇️

scientific article published on December 11, 2012

An outbreak of Pseudomonas aeruginosa ventilator-associated respiratory infections due to contaminated food coloring dye--further evidence of the significance of gastric colonization preceding nosocomial pneumonia

scientific article published in July 1995

Another perspective: reducing the overtreatment of pneumonia

scientific article published in October 2013

Antibiotic Development Incentives That Reflect Societal Value of Antibiotics

scientific article published on 30 January 2020

Antibiotic resistance: a local hospital or community problem

scientific article

Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study

scientific article published on 9 January 2017

Antibiotics and adverse events: the role of antimicrobial stewardship programs in 'doing no harm'

scientific article published on 01 December 2019

Antimicrobial stewardship: importance for patient and public health.

scientific article published in October 2014

Antimicrobial therapy of community-acquired pneumonia

scientific article

Antipseudomonal penicillins

scientific article

Approaches to Modifying the Behavior of Clinicians Who Are Noncompliant With Antimicrobial Stewardship Program Guidelines

scientific article published on 20 April 2016

Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials

scientific article

Atypical pneumonia syndrome.

scientific article

Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial

scientific article published on May 2000

Bacterial Pneumonia in Older Adults

scientific article

Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections

scientific article

Bullous skin lesions associated with Yersinia enterocolitica septicemia.

scientific article published on May 1984

Burden of community-acquired pneumonia in North American adults

scientific article published on March 2010

Campylobacter fetus sepsis with mycotic aortic aneurysm

scientific article published on March 1, 1979

Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?

scientific article published in August 1996

Canine model for the simultaneous measurement of antibiotic levels in tissues and bacterial killing rate

scientific article published on June 1986

Case studies of lower respiratory tract infections: community-acquired pneumonia

scientific article published on April 2010

Causes, Burden, and Prevention of Infection

Cefamandole Nafate Therapy of Respiratory Tract, Skin, and Soft Tissue Infections in 74 Patients ⬇️

scientific article published on May 1, 1978

Cefmenoxime versus Cefoxitin in the Treatment of Serious Bacterial Infections ⬇️

scientific article published on December 21, 1984

Cefoperazone for the treatment of acute urinary tract infection: multicentered comparative and noncomparative studies

scientific article published in March 1983

Cefoperazone versus cefamandole in the treatment of acute bacterial lower respiratory tract infections ⬇️

scientific article published on January 1, 1983

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials

scientific article

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials

scientific article published on 13 April 2016

Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases of America Strategic Plan

scientific article published on 01 November 2019

Chlamydia pneumoniae pneumonia

scientific article published on January 2000

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

article by Timothy M. Uyeki et al published 5 March 2019 in Clinical Infectious Diseases

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

scientific article published on 01 March 2019

Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae.

scientific article

Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia

scientific article published on August 1999

Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia

scientific article

Clinical evaluation of ceftriaxone

scientific article published on January 1, 1984

Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia

scientific article published on September 2004

Community-acquired pneumonia

scientific article published on 01 December 2003

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

scientific article published on April 1998

Community-acquired pneumonia. The changing picture

scientific article published on December 1, 1992

Community-acquired pneumonia. What's needed for accurate diagnosis

scientific article published on January 1996

Community-associated methicillin-resistant Staphylococcus aureas: not only a cause of skin infections, also a new cause of pneumonia

scientific article published in April 2005

Concurrent antibody rises to C psittaci and L pneumophila in a patient with psittacosis

scientific article published in March 1982

Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance

scientific article published on 29 March 2007

Cryptococcal meningitis in renal transplant patients associated with environmental exposure

scientific article published in September 1999

Dermatobia hominis dermal myiasis. A furuncular lesion in a world traveler

scientific article published in September 1985

Determining the Duration of Therapy for Patients with Community-Acquired Pneumonia ⬇️

scientific article published on April 1, 2013

Diagnosis and Treatment of Clostridium difficile Infection (CDI).

scientific article published in January 2016

Diagnosis and treatment of diabetic foot infections

scientific article published on 01 October 1988

Diagnosis and treatment of diabetic foot infections

scientific article published on 01 March 1999

Diagnosis and treatment of staphylococcal diseases

scientific article published in October 1989

Diffusibility of the newer cephalosporins into human interstitial fluids

scientific article published on October 19, 1984

Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia

scientific article published on 2 October 2013

Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey

scientific article published on 21 May 2002

Does Empiric Therapy for Atypical Pathogens Improve Outcomes for Patients with CAP? ⬇️

scientific article published on March 1, 2013

Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme

scientific article published on September 2004

Duration and cessation of antimicrobial treatment ⬇️

scientific article published on January 1, 2012

Early Steps Toward Ambulatory Antimicrobial Stewardship: Dental and Orthopedic Focus

scientific article published on 15 November 2019

Effect of Rapid Molecular Diagnostic Testing and Antimicrobial Stewardship on Antimicrobial Therapy of Respiratory Infections.

scientific article published on 4 October 2017

Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit

scientific article

Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial

scientific article published on 01 November 2019

Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial

scientific article published on 18 October 2019

Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections

scientific article published in July 2001

Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections

scientific article published on January 1, 1994

Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.

scientific article published in February 2005

Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for Hospitals

scientific article

Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia

scientific article published on 14 July 2003

Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA.

scientific article published in February 2013

Empiric antimicrobial therapy of serious urinary tract infections

scientific article published on January 1986

Enterococcal sensitivity to third generation cephalosporins ⬇️

scientific article published on August 29, 1981

Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza ⬇️

scientific article published on March 2, 2012

Etiology and management of community-acquired pneumonia in Asia

scientific article

Evaluation and use of a rapid Staphylococcus aureus assay by an antimicrobial stewardship program

scientific article published on November 2013

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study

scientific article published on 19 February 2020

Evaluation of cefoperazone in the therapy of urinary tract infections ⬇️

scientific article published on March 1, 1982

Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns

scientific article published on June 2004

Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

scientific article published on September 2016

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

scientific article

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia ⬇️

scientific article published on April 1, 2011

Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia

scientific article

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study

scientific article

Gemifloxacin: a new, potent fluoroquinolone for the therapy of lower respiratory tract infections

scientific article

Group A streptococcal necrotizing fasciitis: Diagnosing and treating the "flesh-eating bacteria syndrome"

scientific article published on May 1, 1998

Group A streptococcus necrotizing fasciitis

scientific article

Guidance for the knowledge and skills required for antimicrobial stewardship leaders

scientific article published on December 2014

Guideline tyranny: a response to the article by Baum and Kaltsas

scientific article

Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia

scientific article published on May 2004

High-pressure liquid chromatographic method for analysis of cephalosporins

scientific article

Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study

scientific article

Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults.

scientific article

How long should we treat community-acquired pneumonia?

scientific article

IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults

scientific article

Identifying Barriers to Adult Pneumococcal Vaccination: An NFID Task Force Meeting ⬇️

scientific article published on May 1, 2012

Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infections

scientific article

Impact of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting.

scientific article published on August 2007

Impact of the expansion of antimicrobial stewardship services during transitions of care at an academic hospital

scientific article published on 02 June 2020

Improving Clinical Practice Guidelines—The Answer Is More Clinical Research ⬇️

scientific article published on August 8, 2011

In vitro susceptibility of the Bacteroides fragilis group in community hospitals

scientific article published in November 1986

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

scientific article published on August 1997

Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia

scientific article published on March 1997

Infections due to Corynebacterium group D2. Report of a case

scientific article

Infectious Disease Clinics of North America. Community-acquired pneumonia: controversies and questions. Preface

scientific article published on 19 December 2012

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

scientific article

Infectious complications in diabetic patients

scientific article published in January 1994

Infectious complications in diabetic patients.

scientific article published on January 1997

Infectious complications in diabetic patients.

scientific article published in December 1981

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia ⬇️

scientific article published on November 10, 2010

International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides

scientific article

Is the risk of serious infections increased in patients with RA who receive treatment with antirheumatic drugs?

scientific article published on 4 December 2007

Judicious use of antibiotics to treat respiratory tract infections

scientific article published in April 2002

Keeping our adult patients healthy and active: the role of vaccines across the lifespan

scientific article published on December 2010

Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine

scientific article

Lefamulin: A Novel Semisynthetic Pleuromutilin Antibiotic for Community-Acquired Bacterial Pneumonia

scientific article published on 28 March 2020

Legionella

scientific article published on April 1999

Legionnaires disease with bacteremic coinfection

scientific article published on 31 July 2002

Levels of amdinocillin in human plasma and interstitial fluid following intravenous administration ⬇️

scientific article published on August 29, 1983

Levels of antibiotic in human blood and interstitial fluid after oral administration of bacampicillin or phenoxymethyl penicillin and intravenous administration of amoxicillin or ampicillin

scientific article published in January 1981

Levofloxacin for the treatment of community-acquired pneumonia

scientific article published on October 2006

Lower respiratory tract infections

scientific article published on 01 December 2004

Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point

scientific article published on 6 June 2017

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

scientific article

Management of community-acquired pneumonia: a focus on conversion from hospital to the ambulatory setting

scientific article published on January 2003

Management of staphylococcal and streptococcal infections.

scientific article published on October 1996

Managing patients with recurrent acute exacerbations of chronic bronchitis: a common clinical problem

scientific article published in October 2004

Medication options for the treatment of CAP.

scientific article

Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study

scientific article

Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients

scientific article published on 19 December 2013

Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infections

scientific article published in July 1985

Necrotic Skin Lesions Associated With Disseminated Candidiasis ⬇️

scientific article published on February 1, 1979

Necrotizing Soft Tissue Infections

scientific article published on 01 October 2003

New diagnostic tests for pneumonia: what is their role in clinical practice? ⬇️

scientific article published on July 12, 2011

New insights in the treatment by levofloxacin

scientific article published in January 2004

New millennium: new antimicrobial agents for respiratory infections; but an old plea.

scientific article published in April 2000

Nosocomial (Health Care-Associated) Legionnaire's Disease

scientific article

Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization. Pneumonia Study Group

scientific article

Optimal treatment strategies for community-acquired pneumonia: non-responders to conventional regimens

scientific article

Optimizing therapy for community-acquired pneumonia with the goal of rapid resolution of illness

scientific article published on 10 November 2005

Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical

scientific article

Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate

scientific article published in October 2002

Overview of resistance in the 1990s

scientific article

Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection

scientific article published in July 1999

Pathways to Leadership: Reflections of Recent Infectious Diseases Society of America (IDSA) Leaders During Conception and Launch of the Inclusion, Diversity, Access, and Equity Movement Within the IDSA

scientific article published on 01 September 2020

Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremia

scientific article

Performance measurement in community-acquired pneumonia: consequences intended and unintended

scientific article published on 20 February 2007

Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila

scientific article

Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration ⬇️

scientific article published on July 1, 1992

Pharmacokinetics of intravenous cefmetazole with emphasis on comparison between predicted theoretical levels in tissue and actual skin window fluid levels

scientific article published on June 1989

Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia

scientific article published on 06 May 2019

Pneumococcal vaccine: a different perspective

scientific article published in September 1994

Pneumonia and empyema caused by Clostridium sordellii

scientific article published on September 1, 1977

Pneumonia in older adults: reversing the trend

scientific article published in December 2005

Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections

scientific article published on 19 May 2018

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

scientific article published on 01 August 2000

Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study

scientific article published on 8 November 2006

Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011

scientific article (publication date: 3 May 2016)

Prevention of bloodstream infections: basics and beyond

scientific article published in January 2009

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections

scientific article published on 01 April 2020

Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections. CBPIS Study Group. Community-based Pneumonia Incidence Study

scientific article published on September 1994

Rational use of antibiotics to treat respiratory tract infections

scientific article

Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines

scientific article

Recurrent Cellulitis After Bypass Surgery Associated With Psoriasis ⬇️

scientific article published on October 5, 1984

Reduction of Clostridium difficile Infection in a Community Teaching Hospital Associated with Antimicrobial Stewardship Team Interventions on Fluoroquinolone Utilization

scientific article published on 4 October 2017

Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group

scientific article published in May 1995

Repeat antimicrobial susceptibility testing of identical isolates

scientific article published on May 1989

Reply

Reply to Bush and Kaye

scientific article published on 7 June 2017

Reply to Collins et al. and to Singh

scientific article published in 2007

Reply to Tang and Lai

scientific article published on 11 December 2019

Reporting and publishing guidelines: article 12 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report

scientific article published on December 2012

Respiratory infections unique to Asia

scientific article

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

scientific article published in September 1996

Risk factors for domestic acquisition of legionnaires disease. Ohio legionnaires Disease Group

scientific article

SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.

scientific article

Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment

scientific article published on 13 December 2020

Safety of intravenous infusion of doripenem.

scientific article published in August 2009

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America

scientific article

Severe acute respiratory syndrome: pertinent clinical characteristics and therapy

scientific article

Short-course treatment of community-acquired pneumonia

scientific article published on 28 August 2003

Shorter course therapy of serious respiratory infections: new data for new approaches to management

scientific article published in April 2004

Solutions to the problem of bacterial resistance.

scientific article

Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers

scientific article published on March 1996

Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs.

scientific article published on August 2011

Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern

scientific article published in August 2004

Summary of Ceftaroline Fosamil Clinical Trial Studies and Clinical Safety ⬇️

scientific article published on September 1, 2012

Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe ⬇️

scientific article published on 7 December 2017

Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe ⬇️

scientific article published on 10 September 2018

Team approach in the management of diabetic foot infections.

scientific article published in January 1987

Telithromycin new product overview

scientific article

The Evolving Role of Antimicrobial Stewardship in Management of Multidrug Resistant Infections

scientific article published on June 2016

The Role of Antibiotic Stewardship and Telemedicine in the Management of Multidrug-Resistant Infections

scientific article published on 01 December 2020

The clinical relevance of penicillin-resistant Streptococcus pneumoniae: a new perspective

scientific article published on 8 February 2006

The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults

scientific article published on December 2007

The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogens ⬇️

scientific article published on 20 September 2017

The pattern of gram-negative-rod bacteremia in a community hospital

scientific article

The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study

scientific article published on 15 January 2008

The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group

scientific article published in February 2000

The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection

scientific article published on September 1998

The science of selecting antimicrobials for community-acquired pneumonia (CAP).

scientific article published on March 2009

The use of oral fluoroquinolones in nursing home patients

scientific article published on July 1992

Therapy of Skin, Soft Tissue, and Bone Infections with Cefoxitin Sodium ⬇️

scientific article published on January 1, 1979

Ticarcillin-clavulanate therapy for bacterial skin and soft tissue infections

scientific article published on July 1991

Timentin Versus Piperacillin or Moxalactam in the Therapy of Acute Bacterial Infections

scientific article published in December 1984

Timentin versus moxalactam in the treatment of skin and soft tissue infections

scientific article published in November 1985

Timentin versus piperacillin in the therapy of serious urinary tract infections

scientific article published on November 1985

Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections

scientific article published on September 1984

Treatment of Bacteriuria in Pregnancy ⬇️

scientific article published on December 1, 1992

Treatment of bacterial skin and soft tissue infections

scientific article published on January 1991

Treatment of skin and soft-tissue infections.

scientific article published on May 1995

Update of Legionella infections.

scientific article published on April 1999

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

scientific article

Urinary tract infections in obstetrics and gynecology.

scientific article published on March 1990

Urinary tract infections in the elderly

scientific article published on 01 August 1989

Value of noninvasive studies in community-acquired pneumonia

scientific article published on September 1998

Ventilator-associated pneumonia: gearing towards shorter-course therapy

scientific article

Viral respiratory tract infections: increasing importance and a new pathogen ⬇️

scientific article published on April 1, 2003

What can we learn from the time course of untreated and partially treated community-onset Streptococcus pneumoniae pneumonia? A clinical perspective on superiority and noninferiority trial designs for mild community-acquired pneumonia

scientific article published on December 2008

What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?

scientific article published on 31 January 2003

Yield, clinical significance, and cost of a combination BACTEC plus Septi-Chek blood culture system

scientific article published on May 1987

[Clinical impact of appropriate use of antibiotic in hospital according to CARAT criteria]

scientific article published on 01 April 2008

Paulina is supported by:

About Paulina

Help